Renal function trajectories in hepatitis C infection: differences between renal healthy and chronic kidney disease

Cheng-Kai Hsu1, Tai-Shuan Lai2, Yih-Ting Chen1

  • 1Department of Nephrology, Chang Gung Memorial Hospital, 222, Mai-Chin Road, Keelung, 20401, Taiwan.

Scientific Reports
|August 26, 2021
PubMed

Insights

Hepatitis C virus (HCV) infection significantly increases the risk of developing chronic kidney disease (CKD) and accelerates kidney function decline. Early viral diagnosis is crucial for preserving kidney health in both general and CKD populations.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) infection is linked to chronic kidney disease (CKD), but prospective data on renal progression differences between general and CKD populations are limited.
  • Understanding HCV's impact on kidney function is vital for public health and patient management.

Purpose of the Study:

  • To prospectively evaluate the association between HCV infection and the incidence and progression of CKD.
  • To compare renal outcomes in HCV-infected individuals with normal renal function versus those with pre-existing CKD.

Main Methods:

  • A prospective cohort study followed 1179 participants for 3 years, assessing anti-HCV antibody status.
  • Renal function was monitored using estimated glomerular filtration rate (eGFR) changes and incidence of CKD.
  • Statistical analyses compared risks between HCV-infected and non-HCV-infected participants, including subgroup analyses.

Main Results:

  • HCV infection was more prevalent in CKD patients (47.6%) than in non-CKD subjects (17.7%).
  • HCV infection was independently associated with a 7.9-fold increased risk of incident CKD.
  • HCV-infected individuals showed accelerated eGFR decline over 1, 2, and 3 years, with a significant risk of 50% eGFR decline at 3 years.

Conclusions:

  • HCV infection is a significant risk factor for CKD incidence and progression, impacting both individuals with normal renal function and those with existing CKD.
  • These findings underscore the importance of HCV screening and management for kidney function preservation, with broad public health implications.

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
312
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
274
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
36
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
34
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
210
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
146